Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-Pool IVIG for Persistent ITP in Children
NCT07068126Recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of polyvalent human immunoglobulin in immune thrombocytopenia (ITP), sponsored by Assiut University. Primary endpoints: Bleeding Frequency and Severity at 6 months, Platelet Count Response at 6 months and 1 more. Started Jan 2025; status: recruiting.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07068126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07068126.